CD4 and COVID-19: Blood samples from the COVID-19 patient group in this age range contained lower proportions of CD4+ CD3+ and CD8+CD3+ in PBMC than healthy samples, but we found no significant differences in the proportions of naïve or CD4+ RTE cells (Supplementary Fig. 2A-E).